Maliheh Nazari-Jahantigh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maliheh Nazari-Jahantigh has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Schober
Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany
4 shared publications - Christian Weber
Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität (LMU) München, Munich, Germany
3 shared publications Mengyu Zhu
Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich; Munich, Germany (N.L., K.T., I.M.B., T.G., Q.M., S.L., Y.Z., X.L., M.Z., S.K.P., C.G., R.T.A.M., H.N., Y.L., C.J., A.B., Y.D., P.vH., C.W., M.N.-J., A.S.).
3 shared publicationsFarima Zahedi
Institute for Cardiovascular Prevention, University Hospital, Ludwig-Maximilians-University, Munich, Germany (E.K., R.M., M.Z., F.Z., C.G., R.T.A.M., M.B., M.N.-J., A.S.).
2 shared publicationsIsabelle M. Baatsch
Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich; Munich, Germany (N.L., K.T., I.M.B., T.G., Q.M., S.L., Y.Z., X.L., M.Z., S.K.P., C.G., R.T.A.M., H.N., Y.L., C.J., A.B., Y.D., P.vH., C.W., M.N.-J., A.S.).
2 shared publicationsRemco T.A. Megens
Institute for Cardiovascular Prevention, University Hospital, Ludwig-Maximilians-University, Munich, Germany (E.K., R.M., M.Z., F.Z., C.G., R.T.A.M., M.B., M.N.-J., A.S.).
2 shared publications
Latest Publications
- 9 June 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (23) , 1845-1863
Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis
BACKGROUND: Hypercholesterolemia and a high-fat diet promote 2 macrophage subtypes involved in atherosclerosis by inducing lipid droplet accumulation in foamy macrophages (FMs) and triggering inflammatory activation in non-foamy macrophages (NFMs). MicroRNAs are key regulators of macrophage subtypes in atherosclerosis; for instance, miR-10a-5p limits lipid droplet formation, while miR-155-5p enhances inflammation. miR-147-3p is upregulated by inflammatory stimuli in macrophages and in atherosclerotic lesions, suggesting a potential role in NFMs. METHODS: The role of miR-147-3p in macrophages, with or without enhanced green fluorescent protein expression, in atherosclerosis was examined in Apoe –/– (apolipoprotein E-deficient) mice with a myeloid cell-specific knockout of the microRNA 147 ( Mir147 ) gene. Using live-plaque 4D confocal imaging, we assessed lipid droplets, caspase-3 activation, phagocytosis of apoptotic DNA, cholesterol crystal (CC) formation, mitochondrial function, macrophage migration, and tubular membrane extension formation. Green fluorescent protein-tAgo2 (tagged Argonaute 2) immunoprecipitation combined with prime RNA sequencing was performed using atherosclerotic aortas from Apoe –/– mice that expressed tAgo2 in myeloid cells. The effect of the galectin-3 inhibitor GB1107 was studied using 4D live-plaque imaging. RESULTS: Unlike FMs, NFMs are primarily located in the plaque core and show higher miR-147-3p levels in both mouse and human atherosclerosis. Knocking out Mir147 in myeloid cells increases atherosclerosis, with enhanced CC formation and apoptotic DNA accumulation in necrotic cores. Removing Mir147 reduces mitochondrial activity and elevates caspase-3 activity in NFMs, but not in FMs, and lowers the spare respiratory capacity of plaque macrophages. Moreover, deleting Mir147 impairs NFM uptake of apoptotic DNA, increases extracellular apoptotic DNA, and promotes CC formation. Additionally, Mir147 deficiency in NFMs induces caspase-3 activation in endothelial cells, facilitating the transendothelial extension of FM projections. The Lgals3 transcript, encoding galectin-3, was reduced in the tAgo2 immunoprecipitate after Mir147 knockout. A miR-147-3p binding site in the Lgals3 3’-UTR was functionally confirmed. GB1107 treatment reversed the Mir147 knockout effect in macrophages. CONCLUSIONS: miR-147-3p reduces atherosclerosis by suppressing the harmful effects of NFMs on endothelial cells and by enhancing their clearance of apoptotic DNA through targeting galectin-3. Increasing miR-147-3p levels might thus slow the expansion of the necrotic core and reduce atherothrombosis caused by NFM-induced endothelial damage.
- 9 June 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (23) , 1845-1863
Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis
BACKGROUND: Hypercholesterolemia and a high-fat diet promote 2 macrophage subtypes involved in atherosclerosis by inducing lipid droplet accumulation in foamy macrophages (FMs) and triggering inflammatory activation in non-foamy macrophages (NFMs). MicroRNAs are key regulators of macrophage subtypes in atherosclerosis; for instance, miR-10a-5p limits lipid droplet formation, while miR-155-5p enhances inflammation. miR-147-3p is upregulated by inflammatory stimuli in macrophages and in atherosclerotic lesions, suggesting a potential role in NFMs. METHODS: The role of miR-147-3p in macrophages, with or without enhanced green fluorescent protein expression, in atherosclerosis was examined in Apoe –/– (apolipoprotein E-deficient) mice with a myeloid cell-specific knockout of the microRNA 147 ( Mir147 ) gene. Using live-plaque 4D confocal imaging, we assessed lipid droplets, caspase-3 activation, phagocytosis of apoptotic DNA, cholesterol crystal (CC) formation, mitochondrial function, macrophage migration, and tubular membrane extension formation. Green fluorescent protein-tAgo2 (tagged Argonaute 2) immunoprecipitation combined with prime RNA sequencing was performed using atherosclerotic aortas from Apoe –/– mice that expressed tAgo2 in myeloid cells. The effect of the galectin-3 inhibitor GB1107 was studied using 4D live-plaque imaging. RESULTS: Unlike FMs, NFMs are primarily located in the plaque core and show higher miR-147-3p levels in both mouse and human atherosclerosis. Knocking out Mir147 in myeloid cells increases atherosclerosis, with enhanced CC formation and apoptotic DNA accumulation in necrotic cores. Removing Mir147 reduces mitochondrial activity and elevates caspase-3 activity in NFMs, but not in FMs, and lowers the spare respiratory capacity of plaque macrophages. Moreover, deleting Mir147 impairs NFM uptake of apoptotic DNA, increases extracellular apoptotic DNA, and promotes CC formation. Additionally, Mir147 deficiency in NFMs induces caspase-3 activation in endothelial cells, facilitating the transendothelial extension of FM projections. The Lgals3 transcript, encoding galectin-3, was reduced in the tAgo2 immunoprecipitate after Mir147 knockout. A miR-147-3p binding site in the Lgals3 3’-UTR was functionally confirmed. GB1107 treatment reversed the Mir147 knockout effect in macrophages. CONCLUSIONS: miR-147-3p reduces atherosclerosis by suppressing the harmful effects of NFMs on endothelial cells and by enhancing their clearance of apoptotic DNA through targeting galectin-3. Increasing miR-147-3p levels might thus slow the expansion of the necrotic core and reduce atherothrombosis caused by NFM-induced endothelial damage.
- 1 August 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (8) , 1023-1036
Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice
Background: Maladapted endothelial cells (ECs) secrete ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2; autotaxin)—a lysophospholipase D that generates lysophosphatidic acids (LPAs). ENPP2 derived from the arterial wall promotes atherogenic monocyte adhesion induced by generating LPAs, such as arachidonoyl-LPA (LPA20:4), from oxidized lipoproteins. Here, we aimed to determine the role of endothelial ENPP2 in the production of LPAs and atherosclerosis. Methods: We quantified atherosclerosis in mice harboring loxP-flanked Enpp2 alleles crossed with Apoe –/– mice expressing tamoxifen-inducible Cre recombinase under the control of the EC-specific bone marrow X kinase promoter after 12 weeks of high-fat diet feeding. Results: A tamoxifen-induced EC-specific Enpp2 knockout decreased atherosclerosis, accumulation of lesional macrophages, monocyte adhesion, and expression of endothelial CXCL (C-X-C motif chemokine ligand) 1 in male and female Apoe –/– mice. In vitro, ENPP2 mediated the mildly oxidized LDL (low-density lipoprotein)-induced expression of CXCL1 in aortic ECs by generating LPA20:4, palmitoyl-LPA (LPA16:0), and oleoyl-LPA (LPA18:1). ENPP2 and its activity were detected on the endothelial surface by confocal imaging. The expression of endothelial Enpp2 established a strong correlation between the plasma levels of LPA16:0, stearoyl-LPA (LPA18:0), and LPA18:1 and plaque size and a strong negative correlation between the LPA levels and ENPP2 activity in the plasma. Moreover, endothelial Enpp2 knockout increased the weight of high-fat diet–fed male Apoe –/– mice. Conclusions: We demonstrated that the expression of ENPP2 in ECs promotes atherosclerosis and endothelial inflammation in a sex-independent manner. This might be due to the generation of LPA20:4, LPA16:0, and LPA18:1 from mildly oxidized lipoproteins on the endothelial surface.
- 1 August 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (8) , 1023-1036
Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice
Background: Maladapted endothelial cells (ECs) secrete ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2; autotaxin)—a lysophospholipase D that generates lysophosphatidic acids (LPAs). ENPP2 derived from the arterial wall promotes atherogenic monocyte adhesion induced by generating LPAs, such as arachidonoyl-LPA (LPA20:4), from oxidized lipoproteins. Here, we aimed to determine the role of endothelial ENPP2 in the production of LPAs and atherosclerosis. Methods: We quantified atherosclerosis in mice harboring loxP-flanked Enpp2 alleles crossed with Apoe –/– mice expressing tamoxifen-inducible Cre recombinase under the control of the EC-specific bone marrow X kinase promoter after 12 weeks of high-fat diet feeding. Results: A tamoxifen-induced EC-specific Enpp2 knockout decreased atherosclerosis, accumulation of lesional macrophages, monocyte adhesion, and expression of endothelial CXCL (C-X-C motif chemokine ligand) 1 in male and female Apoe –/– mice. In vitro, ENPP2 mediated the mildly oxidized LDL (low-density lipoprotein)-induced expression of CXCL1 in aortic ECs by generating LPA20:4, palmitoyl-LPA (LPA16:0), and oleoyl-LPA (LPA18:1). ENPP2 and its activity were detected on the endothelial surface by confocal imaging. The expression of endothelial Enpp2 established a strong correlation between the plasma levels of LPA16:0, stearoyl-LPA (LPA18:0), and LPA18:1 and plaque size and a strong negative correlation between the LPA levels and ENPP2 activity in the plasma. Moreover, endothelial Enpp2 knockout increased the weight of high-fat diet–fed male Apoe –/– mice. Conclusions: We demonstrated that the expression of ENPP2 in ECs promotes atherosclerosis and endothelial inflammation in a sex-independent manner. This might be due to the generation of LPA20:4, LPA16:0, and LPA18:1 from mildly oxidized lipoproteins on the endothelial surface.
- 28 September 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (13) , 1059-1073
MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions
Background: The necrotic core partly formed by ineffective efferocytosis increases the risk of an atherosclerotic plaque rupture. Microribonucleic acids contribute to necrotic core formation by regulating efferocytosis and macrophage apoptosis. Atherosclerotic plaque rupture occurs at increased frequency in the early morning, indicating diurnal changes in plaque vulnerability. Although circadian rhythms play a role in atherosclerosis, the molecular clock output pathways that control plaque composition and rupture susceptibility are unclear. Methods: Circadian gene expression, necrotic core size, apoptosis, and efferocytosis in aortic lesions were investigated at different times of the day in Apoe –/– Mir21 +/+ mice and Apoe –/– Mir21 –/– mice after consumption of a high-fat diet for 12 weeks. Genome-wide gene expression and lesion formation were analyzed in bone marrow–transplanted mice. Diurnal changes in apoptosis and clock gene expression were determined in human atherosclerotic lesions. Results: The expression of molecular clock genes, lesional apoptosis, and necrotic core size were diurnally regulated in Apoe –/– mice. Efferocytosis did not match the diurnal increase in apoptosis at the beginning of the active phase. However, in parallel with apoptosis, expression levels of oscillating Mir21 strands decreased in the mouse atherosclerotic aorta. Mir21 knockout abolished circadian regulation of apoptosis and reduced necrotic core size but did not affect core clock gene expression. Further, Mir21 knockout upregulated expression of proapoptotic Xaf1 (XIAP-associated factor 1) in the atherosclerotic aorta, which abolished circadian expression of Xaf1. The antiapoptotic effect of Mir21 was mediated by noncanonical targeting of Xaf1 through both Mir21 strands. Mir21 knockout in bone marrow cells also reduced atherosclerosis and necrotic core size. Circadian regulation of clock gene expression was confirmed in human atherosclerotic lesions. Apoptosis oscillated diurnally in phase with XAF1 expression, demonstrating an early morning peak antiphase to that of the Mir21 strands. Conclusions: Our findings suggest that the molecular clock in atherosclerotic lesions induces a diurnal rhythm of apoptosis regulated by circadian Mir21 expression in macrophages that is not matched by efferocytosis, thus increasing the size of the necrotic core.
- 28 September 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (13) , 1059-1073
MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions
Background: The necrotic core partly formed by ineffective efferocytosis increases the risk of an atherosclerotic plaque rupture. Microribonucleic acids contribute to necrotic core formation by regulating efferocytosis and macrophage apoptosis. Atherosclerotic plaque rupture occurs at increased frequency in the early morning, indicating diurnal changes in plaque vulnerability. Although circadian rhythms play a role in atherosclerosis, the molecular clock output pathways that control plaque composition and rupture susceptibility are unclear. Methods: Circadian gene expression, necrotic core size, apoptosis, and efferocytosis in aortic lesions were investigated at different times of the day in Apoe –/– Mir21 +/+ mice and Apoe –/– Mir21 –/– mice after consumption of a high-fat diet for 12 weeks. Genome-wide gene expression and lesion formation were analyzed in bone marrow–transplanted mice. Diurnal changes in apoptosis and clock gene expression were determined in human atherosclerotic lesions. Results: The expression of molecular clock genes, lesional apoptosis, and necrotic core size were diurnally regulated in Apoe –/– mice. Efferocytosis did not match the diurnal increase in apoptosis at the beginning of the active phase. However, in parallel with apoptosis, expression levels of oscillating Mir21 strands decreased in the mouse atherosclerotic aorta. Mir21 knockout abolished circadian regulation of apoptosis and reduced necrotic core size but did not affect core clock gene expression. Further, Mir21 knockout upregulated expression of proapoptotic Xaf1 (XIAP-associated factor 1) in the atherosclerotic aorta, which abolished circadian expression of Xaf1. The antiapoptotic effect of Mir21 was mediated by noncanonical targeting of Xaf1 through both Mir21 strands. Mir21 knockout in bone marrow cells also reduced atherosclerosis and necrotic core size. Circadian regulation of clock gene expression was confirmed in human atherosclerotic lesions. Apoptosis oscillated diurnally in phase with XAF1 expression, demonstrating an early morning peak antiphase to that of the Mir21 strands. Conclusions: Our findings suggest that the molecular clock in atherosclerotic lesions induces a diurnal rhythm of apoptosis regulated by circadian Mir21 expression in macrophages that is not matched by efferocytosis, thus increasing the size of the necrotic core.
- 1 December 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 273, 199-202
Dicer promotes endothelial recovery and limits lesion formation after vascular injury through miR-126-5p
- 1 December 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 273, 199-202
Dicer promotes endothelial recovery and limits lesion formation after vascular injury through miR-126-5p
- Open Access
- 4 June 2018
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 118 (07) , 1340-1342
Deletion of MFGE8 Inhibits Neointima Formation upon Arterial Damage
Atherosclerosis, a chronic inflammation of the vessel wall, is a major cause for vascular mortality due to narrowing (stenosis) of the arterial wall. In part, artery stenosis is therapeutically addressed by widening the vessel through angioplasty. Although well-established, angioplasty can damage the arterial endothelium, giving rise to an inflammatory response that leads to a neointimal hyperplasia with consequent recurrence of stenosis.[1] [2] Key players in this process are leukocytes and smooth muscle cells (SMCs), as leukocyte recruitment and SMC proliferation and migration are determinants of neointimal hyperplasia.[3] MFGE8 (milk fat globule-epidermal growth factor 8) or lactadherin is mostly regarded as a bridging molecule with a critical function in efferocytosis and, hence, during resolution of inflammation.[4] However, MFGE8 also plays a major role in promoting neovascularization,[5] and, more recently, arterial MFGE8 expression emerged as a molecular hallmark of adverse cardiovascular remodelling upon aging.[6] In this context, MFGE8 is directly associated with SMC proliferation and migration,[6] [7] suggesting its participation in neointima formation. We here show that MFGE8 negatively impacts on arterial restenosis and its neutralization may therefore be a potential therapeutic strategy. To study the role of MFGE8 in arterial restenosis, we subjected two groups of mice, Apoe−/− and Apoe−/−Mfge8−/− , to wire injury of the left carotid artery. To simulate hypercholesterolemia, a condition often present in atherosclerotic patients, the mice were fed a high-fat diet, starting 1 week prior to injury. Two weeks after the injury, the mice were euthanized and the blood and carotids were collected. To assess neointima formation, the carotids were stained for elastic tissue fibres with Verhoeff–Van Gieson stain. Neointima area was significantly smaller throughout the injured carotid in mice lacking MFGE8 as compared with the Apoe−/− group ([Fig. 1A]–[C]). No differences in blood counts were observed between the groups ([Supplementary Table S1], available in the online version), suggesting that the distinct neointima areas are mediated by local cells. However, cholesterol levels in the blood were higher in Apoe−/−Mfge8−/− mice as compared with Apoe−/− , likely a consequence of decreased fatty acid uptake by the liver as well as small intestine, as MFGE8 has been reported to promote fatty acid uptake.[8] [9] To determine which cells contributed the most for the larger neointima observed in Apoe−/− mice, we stained the carotids with antibodies against macrophages and SMCs, since MFGE8 has been reported to be expressed in these cells.[10] [11] Lack of MFGE8 did not affect neointimal macrophages, while SMC areas were vastly reduced ([Fig. 1D], [E]). To assess whether this was the result of reduced cell proliferation, the carotid arteries were stained with an antibody against Ki67, a cellular marker of proliferation. The staining revealed significantly less SMC proliferation in mice lacking MFGE8 as compared with their wild-type littermates, suggesting a determinant role of lactadherin in restenosis formation. To confirm this observation, and verify MFGE8 as a therapeutic target, we subjected Apoe−/− mice to arterial injury combined with the local application of siRNA, either against MFGE8 or scrambled. siRNA against MFGE8 resulted in 50% reduced expression of the protein both in the intima and in the neointima (lesion) area of the carotid artery ([Supplementary Fig. S1], available in the online version). Similar to what was observed in the knockout animal models, analysis of the injured carotids of mice treated with siRNA directed to MFGE8 showed a decreased neointima sizes as compared with mice treated with control siRNA ([Fig. 1G]–[I]). Equally in accordance with the studies in the knockout animal models, no differences in blood counts were observed between the groups ([Supplementary Table S1], available in the online version). Blood cholesterol levels remained unchanged ([Supplementary Fig. S2], available in the online version), supporting the argument presented earlier for the difference observed in the blood of the knockout animal models: since the siRNA effect is strictly local, it does not affect fatty acid uptake. Consistent with the observations in the carotids of Apoe−/− versus Apoe−/−Mfge8−/− mice, the administration of siRNA against MFGE8 affected SMCs' content in the neointima ([Fig. 1K]) and its proliferation ([Fig. 1L]) but the macrophage composition remained unchanged ([Fig. 1J]). Overall, these results strongly point toward a relevant role of MFGE8 in postinjury arterial wall remodelling, with the potential to be exploited for therapeutic purposes. Our studies suggest these effects to be SMC-mediated, more specifically: by stimulating SMC proliferation, MFGE8 promotes the formation of neointima possibly leading to hyperplasia and consequent stenosis. Note: The review process for this paper was fully handled by Gregory Y. H. Lip, Editor-in-Chief.
- 4 June 2018
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 118 (07) , 1340-1342
Open AccessDeletion of MFGE8 Inhibits Neointima Formation upon Arterial Damage
Atherosclerosis, a chronic inflammation of the vessel wall, is a major cause for vascular mortality due to narrowing (stenosis) of the arterial wall. In part, artery stenosis is therapeutically addressed by widening the vessel through angioplasty. Although well-established, angioplasty can damage the arterial endothelium, giving rise to an inflammatory response that leads to a neointimal hyperplasia with consequent recurrence of stenosis.[1] [2] Key players in this process are leukocytes and smooth muscle cells (SMCs), as leukocyte recruitment and SMC proliferation and migration are determinants of neointimal hyperplasia.[3] MFGE8 (milk fat globule-epidermal growth factor 8) or lactadherin is mostly regarded as a bridging molecule with a critical function in efferocytosis and, hence, during resolution of inflammation.[4] However, MFGE8 also plays a major role in promoting neovascularization,[5] and, more recently, arterial MFGE8 expression emerged as a molecular hallmark of adverse cardiovascular remodelling upon aging.[6] In this context, MFGE8 is directly associated with SMC proliferation and migration,[6] [7] suggesting its participation in neointima formation. We here show that MFGE8 negatively impacts on arterial restenosis and its neutralization may therefore be a potential therapeutic strategy. To study the role of MFGE8 in arterial restenosis, we subjected two groups of mice, Apoe−/− and Apoe−/−Mfge8−/− , to wire injury of the left carotid artery. To simulate hypercholesterolemia, a condition often present in atherosclerotic patients, the mice were fed a high-fat diet, starting 1 week prior to injury. Two weeks after the injury, the mice were euthanized and the blood and carotids were collected. To assess neointima formation, the carotids were stained for elastic tissue fibres with Verhoeff–Van Gieson stain. Neointima area was significantly smaller throughout the injured carotid in mice lacking MFGE8 as compared with the Apoe−/− group ([Fig. 1A]–[C]). No differences in blood counts were observed between the groups ([Supplementary Table S1], available in the online version), suggesting that the distinct neointima areas are mediated by local cells. However, cholesterol levels in the blood were higher in Apoe−/−Mfge8−/− mice as compared with Apoe−/− , likely a consequence of decreased fatty acid uptake by the liver as well as small intestine, as MFGE8 has been reported to promote fatty acid uptake.[8] [9] To determine which cells contributed the most for the larger neointima observed in Apoe−/− mice, we stained the carotids with antibodies against macrophages and SMCs, since MFGE8 has been reported to be expressed in these cells.[10] [11] Lack of MFGE8 did not affect neointimal macrophages, while SMC areas were vastly reduced ([Fig. 1D], [E]). To assess whether this was the result of reduced cell proliferation, the carotid arteries were stained with an antibody against Ki67, a cellular marker of proliferation. The staining revealed significantly less SMC proliferation in mice lacking MFGE8 as compared with their wild-type littermates, suggesting a determinant role of lactadherin in restenosis formation. To confirm this observation, and verify MFGE8 as a therapeutic target, we subjected Apoe−/− mice to arterial injury combined with the local application of siRNA, either against MFGE8 or scrambled. siRNA against MFGE8 resulted in 50% reduced expression of the protein both in the intima and in the neointima (lesion) area of the carotid artery ([Supplementary Fig. S1], available in the online version). Similar to what was observed in the knockout animal models, analysis of the injured carotids of mice treated with siRNA directed to MFGE8 showed a decreased neointima sizes as compared with mice treated with control siRNA ([Fig. 1G]–[I]). Equally in accordance with the studies in the knockout animal models, no differences in blood counts were observed between the groups ([Supplementary Table S1], available in the online version). Blood cholesterol levels remained unchanged ([Supplementary Fig. S2], available in the online version), supporting the argument presented earlier for the difference observed in the blood of the knockout animal models: since the siRNA effect is strictly local, it does not affect fatty acid uptake. Consistent with the observations in the carotids of Apoe−/− versus Apoe−/−Mfge8−/− mice, the administration of siRNA against MFGE8 affected SMCs' content in the neointima ([Fig. 1K]) and its proliferation ([Fig. 1L]) but the macrophage composition remained unchanged ([Fig. 1J]). Overall, these results strongly point toward a relevant role of MFGE8 in postinjury arterial wall remodelling, with the potential to be exploited for therapeutic purposes. Our studies suggest these effects to be SMC-mediated, more specifically: by stimulating SMC proliferation, MFGE8 promotes the formation of neointima possibly leading to hyperplasia and consequent stenosis. Note: The review process for this paper was fully handled by Gregory Y. H. Lip, Editor-in-Chief.